Search Ontology:
ChEBI
nafarelin
- Term ID
- CHEBI:7445
- Synonyms
-
- (2S)-N-(2-amino-2-oxoethyl)-1-{(2S,5S,8R,11S,14S,17S,20S)-2-(3-carbamimidamidopropyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-20-(1H-imidazol-4-ylmethyl)-17-(1H-indol-3-ylmethyl)-5-(2-methylpropyl)-8-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22-heptaoxo-22-
- 5-oxo-L-prolyl L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-3-(2-naphthyl)-D-alanyl-L-leucyl-L-arginyl-L-prolylglycinamide
- [6-D-(2-naphthyl)alanine]-GnRH
- L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-3-(2-naphthyl)-D-alanyl-L-leucyl-L-arginyl-L-prolyl-glycinamide
- nafarelin
- nafarelina
- nafareline
- nafarelinum
- Definition
- An oligopeptide comprising of 5-oxo-L-proline, L-histidine, L-tryptophan, L-serine, L-tyrosine, 3-(2-naphthyl)-D-alanine, L-leucine, L-arginine and L-prolylglycinamide residues joined sequence by peptide linkages. It is a gonadotropin releasing hormone agonist that is used to treat central precocious puberty in children and endometriosis in women.
- References
-
- CAS:76932-56-4
- Chemspider:10605761
- DrugBank:DB00666
- Drug_Central:1868
- HMDB:HMDB0014804
- KEGG:C07613
- KEGG:D08241
- PMID:10900577
- PMID:10900582
- PMID:10983507
- PMID:11212082
- PMID:11228063
- PMID:11788185
- PMID:1386133
- PMID:1531580
- PMID:16038370
- PMID:2143265
- PMID:28430010
- PMID:7716957
- PMID:8569395
- PMID:8967550
- PMID:9209899
- PMID:9252932
- PMID:9663373
- Wikipedia:Nafarelin
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
- inverse has_part
-
Phenotype
Phenotype resulting from nafarelin
Phenotype where environments contain nafarelin
Phenotype modified by environments containing nafarelin
Human Disease / Model Data